Transcranial magnetic stimulation (TMS) targeting the cerebellum may reduce seizure frequency in patients with drug-resistant epilepsy (DRE), according to a small, randomized, controlled crossover trial that involved alternating participants between active stimulation and sham treatment.
Epilepsy Agency of the Big Bend (EABB)
Serving the Big Bend
